Enfusion, Inc. Class A

The momentum for this stock is not very good. Enfusion, Inc. Class A is not a good value stock. Enfusion, Inc. Class A is not very popular among insiders. Tradey thinks it is not wise to invest in Enfusion, Inc. Class A.

News

Head to Head Contrast: Enfusion (NYSE:ENFN) vs. AvePoint (NASDAQ:AVPT)

Zolmax AvePoint (NASDAQ:AVPT - Get Free Report) and Enfusion (NYSE:ENFN - Get Free Report) are both business services companies, but which is the better business? We will compare the two companies based on...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion...\n more…

Implied Volatility Surging for Enfusion (ENFN) Stock Options

Zacks Investment Research Investors in Enfusion, Inc. ENFN need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 15, 2024 $2.50 Call had some of the highest implied...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN

Short Interest in Enfusion, Inc. (NYSE:ENFN) Grows By 19.1%

Ticker Report Enfusion, Inc. (NYSE:ENFN - Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 2,310,000 shares, a growth of 19.1...\n more…

Should You Believe in Enfusion's (ENFN) Healthy Revenue Growth And Margin Expansion in the Future?

Insider Monkey Next Century Growth Investors, LLC, an investment Management Company, released its Small Cap Strategy second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The equities...\n more…